Kuesap Jiraporn, Chaijaroenkul W, Rungsihirunrat K, Pongjantharasatien K, Na-Bangchang Kesara
Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.
Center of Excellence for Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.
Korean J Parasitol. 2015 Jun;53(3):265-70. doi: 10.3347/kjp.2015.53.3.265. Epub 2015 Jun 30.
Hemoglobinopathy and malaria are commonly found worldwide particularly in malaria endemic areas. Thalassemia, the alteration of globin chain synthesis, has been reported to confer resistance against malaria. The prevalence of thalassemia was investigated in 101 malaria patients with Plasmodium falciparum and Plasmodium vivax along the Thai-Myanmar border to examine protective effect of thalassemia against severe malaria. Hemoglobin typing was performed using low pressure liquid chromatography (LPLC) and α-thalassemia was confirmed by multiplex PCR. Five types of thalassemia were observed in malaria patients. The 2 major types of thalassemia were Hb E (18.8%) and α-thalassemia-2 (11.9%). There was no association between thalassemia hemoglobinopathy and malaria parasitemia, an indicator of malaria disease severity. Thalassemia had no significant association with P. vivax infection, but the parasitemia in patients with coexistence of P. vivax and thalassemia was about 2-3 times lower than those with coexistence of P. falciparum and thalassemia and malaria without thalassemia. Furthermore, the parasitemia of P. vivax in patients with coexistence of Hb E showed lower value than coexistence with other types of thalassemia and malaria without coexistence. Parasitemia, hemoglobin, and hematocrit values in patients with coexistence of thalassemia other than Hb E were significantly lower than those without coexistence of thalassemia. Furthermore, parasitemia with coexistence of Hb E were 2 times lower than those with coexistence of thalassemia other than Hb E. In conclusion, the results may, at least in part, support the protective effect of thalassemia on the development of hyperparasitemia and severe anemia in malaria patients.
血红蛋白病和疟疾在世界范围内普遍存在,尤其是在疟疾流行地区。地中海贫血,即珠蛋白链合成的改变,据报道可赋予对疟疾的抗性。在泰国-缅甸边境的101例感染恶性疟原虫和间日疟原虫的疟疾患者中调查了地中海贫血的患病率,以检验地中海贫血对重症疟疾的保护作用。使用低压液相色谱法(LPLC)进行血红蛋白分型,并通过多重PCR确认α地中海贫血。在疟疾患者中观察到五种类型的地中海贫血。两种主要类型的地中海贫血是Hb E(18.8%)和α地中海贫血-2(11.9%)。地中海贫血血红蛋白病与疟疾寄生虫血症(疟疾疾病严重程度的指标)之间没有关联。地中海贫血与间日疟原虫感染没有显著关联,但间日疟原虫和地中海贫血共存患者的寄生虫血症比恶性疟原虫和地中海贫血共存患者以及无地中海贫血的疟疾患者低约2至3倍。此外,Hb E共存患者中间日疟原虫的寄生虫血症值低于与其他类型地中海贫血共存以及无地中海贫血共存的患者。除Hb E外,地中海贫血共存患者的寄生虫血症、血红蛋白和血细胞比容值显著低于无地中海贫血共存的患者。此外,Hb E共存患者的寄生虫血症比除Hb E外的地中海贫血共存患者低2倍。总之,这些结果可能至少部分支持地中海贫血对疟疾患者高寄生虫血症和严重贫血发展的保护作用。